Compound Detail
CHEMBL3621988
TUCIDINOSTAT 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL3621988 |
| Name | TUCIDINOSTAT |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | SZMJVTADHFNAIS-BJMVGYQFSA-N |
50
Targets
129
Activities
1
Assay Types
30
PK Parameters
20
Publications
7
Known Names
20
Indications
Molecular Properties
390.4
MW (Da)
3.38
ALogP
4
HBA
3
HBD
97.1
PSA (Ų)
0.44
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Breast Neoplasms Breast Neoplasms Lymphoma Lymphoma, Large B-Cell, Diffuse Lymphoma, T-Cell Lymphoma, T-Cell, Peripheral Lymphoma, T-Cell, Peripheral Neoplasms Carcinoma, Adenoid Cystic Carcinoma, Neuroendocrine Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Colorectal Neoplasms Esophageal Neoplasms Granuloma, Lethal Midline HIV Infections HIV Infections Hodgkin Disease Immunoblastic Lymphadenopathy Leukemia, Biphenotypic, Acute
ATC Classification
L01XH06
tucidinostat
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS
Activity Summary
IC50 129 meas. best 8.66
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| HL-60 CHEMBL383 | IC50 | 8.66 | 6.345 | 2.2 | 4 |
| Histone deacetylase 1 CHEMBL325 | IC50 | 8.05 | 6.9037 | 9.0 | 19 |
| HEL CHEMBL613888 | IC50 | 7.89 | 6.82 | 13.0 | 2 |
| Histone deacetylase 2 CHEMBL1937 | IC50 | 7.32 | 6.7791 | 48.2 | 11 |
| Histone deacetylase 3 CHEMBL1829 | IC50 | 7.2 | 6.708 | 63.3 | 10 |
| Polyamine deacetylase HDAC10 CHEMBL5103 | IC50 | 7.11 | 6.816 | 78.0 | 5 |
| Histone deacetylase CHEMBL2093865 | IC50 | 6.78 | 5.6867 | 167.0 | 3 |
| NCI-H446 CHEMBL612440 | IC50 | 6.62 | 6.62 | 240.0 | 1 |
| K562 CHEMBL385 | IC50 | 6.5 | 5.8586 | 320.0 | 7 |
| Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2) CHEMBL2111363 | IC50 | 6.48 | 6.48 | 330.0 | 1 |
| HCT-116 CHEMBL394 | IC50 | 6.47 | 5.8188 | 340.0 | 8 |
| Histone deacetylase 11 CHEMBL3310 | IC50 | 6.4 | 6.2967 | 400.0 | 3 |
| DOHH-2 CHEMBL2366181 | IC50 | 6.35 | 6.315 | 449.0 | 2 |
| TMD8 CHEMBL4296503 | IC50 | 6.32 | 6.32 | 480.0 | 1 |
| SKM-1 CHEMBL2366085 | IC50 | 6.26 | 6.26 | 549.0 | 1 |
| SU-DHL-2 CHEMBL4523560 | IC50 | 6.25 | 6.25 | 560.0 | 1 |
| CAKI-1 CHEMBL614067 | IC50 | 6.24 | 6.24 | 570.0 | 1 |
| RS4-11 CHEMBL2366159 | IC50 | 6.22 | 6.22 | 600.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 6.21 | 5.6533 | 619.0 | 3 |
| 786-0 CHEMBL613102 | IC50 | 6.2 | 6.2 | 630.0 | 1 |
| CCRF-CEM CHEMBL382 | IC50 | 6.2 | 6.0933 | 630.0 | 3 |
| ES-2 CHEMBL5058622 | IC50 | 6.17 | 6.17 | 669.0 | 1 |
| Histone deacetylase 8 CHEMBL3192 | IC50 | 6.16 | 6.108 | 700.0 | 5 |
| MOLT-4 CHEMBL614177 | IC50 | 6.12 | 6.12 | 750.0 | 1 |
| MV4-11 CHEMBL613835 | IC50 | 6.11 | 5.77 | 783.0 | 2 |
| Rec1 CHEMBL4483266 | IC50 | 6.0 | 6.0 | 1010.0 | 1 |
| CWR22R CHEMBL612657 | IC50 | 5.97 | 5.97 | 1080.0 | 1 |
| Jurkat CHEMBL397 | IC50 | 5.92 | 5.92 | 1202.0 | 1 |
| DU-145 CHEMBL613508 | IC50 | 5.83 | 5.83 | 1490.0 | 1 |
| PC-9 CHEMBL614102 | IC50 | 5.77 | 5.77 | 1714.0 | 1 |
| MIA PaCa-2 CHEMBL614725 | IC50 | 5.77 | 5.77 | 1682.0 | 1 |
| HepG2 CHEMBL395 | IC50 | 5.7 | 5.505 | 2000.0 | 2 |
| Nicotinamide phosphoribosyltransferase CHEMBL1744525 | IC50 | 5.68 | 5.68 | 2100.0 | 2 |
| NCI-H460 CHEMBL396 | IC50 | 5.63 | 5.63 | 2340.0 | 1 |
| HuT78 CHEMBL613978 | IC50 | 5.62 | 5.62 | 2420.0 | 1 |
| NCI-H441 CHEMBL1075542 | IC50 | 5.58 | 5.58 | 2620.0 | 1 |
| HeLa CHEMBL399 | IC50 | 5.58 | 5.58 | 2623.0 | 1 |
| MDA-MB-468 CHEMBL614335 | IC50 | 5.58 | 5.58 | 2650.0 | 1 |
| A549 CHEMBL392 | IC50 | 5.55 | 5.1967 | 2790.0 | 3 |
| EBC-1 CHEMBL4296411 | IC50 | 5.54 | 5.54 | 2900.0 | 1 |
| LNCaP CHEMBL612518 | IC50 | 5.54 | 5.54 | 2890.0 | 1 |
| PC-3 CHEMBL390 | IC50 | 5.51 | 5.375 | 3091.0 | 2 |
| MC-38 CHEMBL612821 | IC50 | 5.48 | 5.48 | 3300.0 | 1 |
| U-937 CHEMBL612794 | IC50 | 5.48 | 5.405 | 3300.0 | 2 |
| NCI-N87 CHEMBL614197 | IC50 | 5.34 | 5.34 | 4515.0 | 1 |
| HT-29 CHEMBL384 | IC50 | 5.34 | 5.28 | 4570.0 | 2 |
| Unchecked CHEMBL612545 | IC50 | 5.25 | 5.25 | 5570.0 | 1 |
| HEK293 CHEMBL614818 | IC50 | 5.21 | 5.21 | 6244.0 | 1 |
| SK-OV-3 CHEMBL614925 | IC50 | 5.07 | 5.07 | 8460.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 4.54 | 4.54 | 29070.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 873.76 | ng.hr.mL-1 | Homo sapiens |
| AUC | 1349.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 3517.0 | ng.hr.mL-1 | Mus musculus |
| CL | 4.98 | mL.min-1.g-1 | Homo sapiens |
| CL | 5.76 | mL.min-1.g-1 | Canis lupus familiaris |
| CL | 10.35 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 4.18 | mL.min-1.g-1 | Homo sapiens |
| CL | 11.2 | mL.min-1.g-1 | Macaca mulatta |
| CL | 2.76 | mL.min-1.g-1 | Canis lupus familiaris |
| CL | 7.35 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 2.76 | mL.min-1.g-1 | Canis lupus familiaris |
| CL | 1.7 | mL.min-1.g-1 | Homo sapiens |
| CL | 11.2 | mL.min-1.g-1 | Macaca fascicularis |
| CL | 7.35 | mL.min-1.g-1 | Rattus norvegicus |
| Cmax | 312.0 | nM | Homo sapiens |
| Cmax | 3117.16 | nM | Mus musculus |
| F | 20.8 | % | Mus musculus |
| MRT | 4.2 | hr | Mus musculus |
| T1/2 | 24.0 | hr | Homo sapiens |
| T1/2 | 4.6 | hr | Homo sapiens |
| T1/2 | 5.033 | hr | Canis lupus familiaris |
| T1/2 | 3.167 | hr | Rattus norvegicus |
| T1/2 | 6.267 | hr | Homo sapiens |
| T1/2 | 2.05 | hr | Macaca mulatta |
| T1/2 | 8.367 | hr | Canis lupus familiaris |
| T1/2 | 3.167 | hr | Rattus norvegicus |
| T1/2 | 16.33 | hr | Canis lupus familiaris |
| T1/2 | 8.833 | hr | Rattus norvegicus |
| T1/2 | 6.267 | hr | Homo sapiens |
| T1/2 | 1.3 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 36736154 | 10.1016/j.ejmech.2023.115140 | U-937 | 22 |
| 36736154 | 10.1016/j.ejmech.2023.115140 | HL-60 | 22 |
| 34954594 | 10.1016/j.ejmech.2021.114049 | ADMET | 15 |
| 34995925 | 10.1016/j.ejmech.2021.114082 | ADMET | 14 |
| 31938461 | 10.1021/acsmedchemlett.9b00407 | Nicotinamide phosphoribosyltransferase | 11 |
| 30802729 | 10.1016/j.ejmech.2019.02.032 | ADMET | 6 |
| 35649291 | 10.1016/j.ejmech.2022.114484 | HCT-116 | 5 |
| 36736154 | 10.1016/j.ejmech.2023.115140 | Unchecked | 3 |
| 36736154 | 10.1016/j.ejmech.2023.115140 | Kasumi 1 | 3 |
| - | 10.1039/C4MD00350K | Homo sapiens | 3 |
| 34954594 | 10.1016/j.ejmech.2021.114049 | MDA-MB-231 | 2 |
| - | 10.1039/C4MD00350K | NON-PROTEIN TARGET | 2 |
| 31938461 | 10.1021/acsmedchemlett.9b00407 | HCT-116 | 2 |
| 31938461 | 10.1021/acsmedchemlett.9b00407 | K562 | 2 |
| 31938461 | 10.1021/acsmedchemlett.9b00407 | HL-60 | 2 |
| 31938461 | 10.1021/acsmedchemlett.9b00407 | HEL | 2 |
| 34954594 | 10.1016/j.ejmech.2021.114049 | HCT-116 | 2 |
| 34954594 | 10.1016/j.ejmech.2021.114049 | TMD8 | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 34954594 | 10.1016/j.ejmech.2021.114049 | A549 | 2 |
Data from ChEMBL 36 via Core Engine